Management ChangeApr 16, 2026, 08:59 AM
Achieve Life Sciences Names New CEO, Adds Board Members, Secures $354M Financing
AI Summary
Achieve Life Sciences appointed Andrew D. Goldberg, MD, as its new Chief Executive Officer and a Board member, effective after the closing of a recently announced financing. Richard Stewart, the outgoing President & CEO, will remain on the Board. The company also added two new independent directors, Lucian Iancovici, MD, and Aaron E. Royston, MD. This leadership and financial boost, including up to $354 million in financing, aims to strengthen Achieve's position for the development and potential launch of cytisinicline as a new treatment for nicotine dependence.
Key Highlights
- Andrew D. Goldberg, MD, appointed as new CEO and Board member.
- Richard Stewart transitions from CEO to remain on the Board.
- Two new independent directors, Lucian Iancovici and Aaron E. Royston, appointed.
- Secured financing of up to $354 million.
- Financing includes $180 million upfront.